本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Artiva Biotherapeutics, Inc.

2.47
+0.02000.82%
盘后2.35-0.1200-4.86%18:45 EDT
成交量:24.75万
成交额:59.87万
市值:6,017.69万
市盈率:-0.43
高:2.52
开:2.46
低:2.36
收:2.45
数据加载中...
2025/03/24

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/03/24

重要事件披露

Form 8-K - Current report
2025/01/29

重要事件披露

Form 8-K - Current report
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/12

重要事件披露

Form 8-K - Current report
2024/10/22

重要事件披露

Form 8-K - Current report
2024/09/03

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/08/29

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/29

重要事件披露

Form 8-K - Current report
2024/08/01

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/08/01

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/08/01

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/07/29

超过5%披露

Form SC 13D - General Statement of Acquisition of Beneficial Ownership
2024/07/29

超过5%披露

Form SC 13D - General Statement of Acquisition of Beneficial Ownership
2024/07/22

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/07/22

重要事件披露

Form 8-K - Current report
2024/07/17

SEC问询函

Form CORRESP - Correspondence
2024/07/17

SEC问询函

Form CORRESP - Correspondence
2024/07/15

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]